The global respiratory drug delivery market is expected to reach $5237 billion by 2021, from $36.1 billion in 2016 with an average annual growth rate of 6% over the forecast period. The growth of this market is primarily driven by increased preference for pulmonary drug delivery pathways, increased development of technology in the form of smart/digital inhalers, and increased incidence of respiratory diseases such as COPD, asthma and cystic fibrosis.
A full report of Respiratory Drug Delivery Market available at https://www.orionmarketreports.com/pulmonary-drug-delivery-systems-market/47129/
Respiratory Drug Delivery Market Segmentations
By Product
• Scanners
• Software
• Storage & Communication Systems
• Application
• Teleconsultation
• Disease Diagnosis
• Drug Discovery
• Training & Education
By End User
• Educational
• Clinical
• Pharma & Biotech Companies
Major Players
• 3DHistech Ltd
• Mikroscan Technologies Inc.
• Nikon Corporation
• Hamamatsu Photonics KK
• Leica Biosystems Nussloch GmbH
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
